NeoGenomics raises $316M in new convertible notes, retires $276M of existing debt at discount

Filed June 22, 2026 · Period ending June 16, 2026 · ~1 min read

Key Changes

• high

  Issued $316.25M in 0.75% convertible senior notes due 2032, convertible at $14.16/share (35% premium to $10.49 market price); up to 30.1M shares may be issued upon conversion, representing potential dilution.

  Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
• high

  Repurchased $276M principal amount of existing 0.25% convertible notes due 2028 for $263.2M cash, capturing a 4.6% discount to par and reducing outstanding convertible debt obligations.

  Item 8.01 — Other Events verify on EDGAR →
• medium

  Bought back $25M of common stock at $10.49/share (approximately 2.4M shares) from certain new note purchasers in privately negotiated transactions.

  Item 8.01 — Other Events verify on EDGAR →